Stargardt
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Safety and Efficacy of ZVS106e in the Treatment of IRDs Caused by Biallelic Mutations in ABCA4 (NCT07241169) | Zhongshan Ophthalmic Center, Sun Yat-sen University | 2025-12-29 |
| An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene (NCT06435000) | Splice Bio | 2024-03-29 |
Track Stargardt automatically
Every clearance here is in the API, with alerts when new ones post.